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Protein crystallization in confined geometries
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We studied the crystallization of a globular protein, lysozyme, in the cubic phase of the lipid
monoolein. The solubility of lysozyme in salt solution decreased by a factor of ∼ 4 when confined
in cubic phase. Calculations and Monte Carlo simulations show that this can be explained by the
confinement of lysozyme molecules to the narrow water cells in the cubic phase.
We report a study of the crystallization of lysozyme,
a globular protein, in the cubic phase of monoolein, an
uncharged lipid. The protein solubility was found to de-
crease by a factor of ∼ 4. We account for this obser-
vation by the confinement of lysozyme molecules within
nanoscopic water ‘cells’ in the cubic phase. The result-
ing entropy-driven rise in their chemical potential can ex-
plain our observation of solubility suppression compared
to the lipid-free case. The generic nature of this expla-
nation means that our results are of potential interest
to three rather different audiences. First, and most gen-
erally, scientists interested in the basic physics of con-
finement [1] may find the lysozyme-monoolein system a
useful model for detailed study. Secondly, there is grow-
ing interest in directing the self-assembly of synthetic or
natural nanoparticles using various means of confinement
(e.g. at an interface [2] or in emulsion droplets [3]). Our
work suggests that lipid cubic phases can be useful in
this regard. Thirdly, and most specifically, lipid cubic
phases offer an environment for globular protein crystal-
lization [4]. (Their use for crystallizing membrane pro-
teins [5], which reside in the lipid bilayers, relies on dif-
ferent physics [6, 7].)
Lysozyme crystallization in lipid cubic phase has been
reported before [8], although to date there is no com-
plete phase diagram or physical explanation of the mech-
anism. We have studied the phase behavior of lysozyme
solution as a function of protein and salt concentration
in a monoolein cubic phase, and compared it with the
case without lipids. The cubic phase was found to lower
the solubility dramatically. This result was then explored
using simple calculations and Monte Carlo simulations.
Lysozyme and monoolein (MO) were used as purchased
from Sigma-Aldrich. Protein concentration in 0.05 M
sodium acetate buffer was determined, after filtration
through a 0.1 µm Millipore filter, by UV spectropho-
tometry (specific absorbance A280nm = 2.64 ml/mg.cm).
NaCl solutions of known concentration were then added.
We first determined the bulk solubility boundary of
lysozyme/salt without lipid from the dissolution of ‘seed’
crystals [4], which occurs at lower protein and salt con-
centrations than the bulk nucleation boundary (where
crystals are first seen) [9] due to the nucleation barrier
[4]. Next protein/salt solutions with concentrations be-
low the bulk solubility boundary was added to and vig-
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FIG. 1: An optical micrograph of lysozyme crystals in
monoolein cubic phase. Note the curved piece of solid in-
clusion; other crystals grow next to surfaces.
orously mixed with MO powder melted on a microscope
slide. A highly viscous cubic phase was observed to form
almost instantly. The excess solution was then removed
and the cubic phase sealed under a cover slip (sample
thickness ∼ 100 µm) for observation in an optical micro-
scope at 18◦C. All samples were transparent and optically
isotropic under cross polarizers. Within two months,
crystals were observed in many samples, e.g. Fig. 1.
Fig. 2 summarizes our observations in the form of a
phase diagram. We give lysozyme concentrations, c, in
mg/ml, and in terms of an effective volume fraction, φ,
by modelling the globular protein as a sphere of diameter
3.4 nm (which reproduces the molecular volume). Note
that for the data points recording behavior in cubo, the
protein/salt concentrations given are those of the parent
solution into which MO powder was added. The bound-
ary above which we observed crystals in cubo (a kinetic
nucleation boundary) lies entirely below the bulk solu-
bility boundary. Since we expect the in cubo solubility
boundary to lie at even lower protein/salt concentrations,
our main experimental finding is that lipid cubic phase
significantly depresses lysozyme solubility.
To understand this observation, we first note that the
bicontinuous water in the cubic phase is made up of cells
connected by narrow ‘necks’. The presence of lysozyme
changes the MO cubic phase structure from Pn3m to
Im3m [10], a schematic projection of which is shown in
Fig. 3(a) with an inter-cell distance of 12.5 nm [10] and
bilayer thickness of 3.5 nm [6]. We have also shown a
number of lysozyme molecules (hatched circles) modelled
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FIG. 2: The phase diagram of lysozyme/NaCl in bulk solu-
tion and in MO cubic phase. Filled triangles (N) represent the
solubility limit in bulk solution. Other symbols represent be-
havior in the cubic phase: homogeneous solution (×), crystals
(), and other precipitates (△). The lines are guides to the
eye. Inset (same axes), the concentration of the samples in
the cubic phase is multiplied by 4, to nearly superimpose the
nucleation boundary in cubo on the bulk solubility boundary.
as spheres with diameter σ = 3.4 nm. Since the bending
rigidity of the bilayers is kc ≈ 9kBT at room temperature
[11], proteins cannot move between cells without incur-
ring significant cost in distorting the connecting ‘necks’.
Thus the lysozyme will largely be confined in nanoscopic
water ‘cells’ with linear dimension. 10 nm, each of which
can hold up to 7 lysozyme molecules [10, 12]. The cen-
ter of a lysozyme molecule does not come closer than
∼ σ/2 = 1.7 nm to a bilayer. While such excluded vol-
ume is a small effect in the bulk, it is highly significant
inside a water ‘cell’ in the cubic phase, leading to a large
increase in the effective protein concentration. This ex-
plains why crystallization occurred at lower average pro-
tein concentration.
Enquiring where the crystals actually nucleate gives
further understanding. The critical nucleus in our exper-
iments is expected to consist of> 10 lysozymes [13], more
than an undistorted water ‘cell’ can hold. Moreover, a
(tetragonal) unit cell contains 8 molecules [14], and it is
unlikely that crystals can nucleate in pores smaller than
a few unit cells [15]. Experimentally, we often observed
crystals next to solid inclusions or next to surfaces, Fig. 1.
We therefore propose a role for defects.
The picture is as follows. The protein in bulk so-
lution has a concentration-dependent chemical poten-
tial µ(c). Confinement in cubo increases the effective
lysozyme concentration to c′ > c, and its chemical po-
tential to µ(c′) > µ(c). There are defects in the cubic
phase of mesoscopic sizes (≫ lysozyme diameters), due
to grain boundaries, distortion by inclusions, or surfaces.
In these defects, the chemical potential of lysozyme is ini-
tially at µ(c), but diffusion from the ‘loaded’ cubic phase
rapidly increases this to close to µ(c′). Crystals nucleate
from this concentrated solution residing in the defects.
Subsequently, as a crystal grows, it will break the sur-
rounding matrix; the elasticity of the cubic phase may
therefore affect the rate of crystal growth.
Support for the above picture comes from mea-
suring the time-dependent protein concentration in
lysozyme/salt solution in contact with the cubic phase
formed by mixing it with MO. We observed (data not
shown) a rapid increase in concentration that continued
for many hours, showing that indeed µ(c′) > µ(c).
To explore quantitatively our proposed picture, we
used Monte Carlo (MC) simulations to study attractive
hard spheres confined within a ‘model cubic phase’. To
do this, we first need a numerical estimate of the excluded
volume effect. The center of a lysozyme molecule con-
fined to a water ‘cell’ in the cubic phase cannot explore
the whole of the cell volume, Vc, but only the accessible
volume, Va, given by taking off the volume of a layer of
thickness σ/2 from Vc. The ratio α = Vc/Va characterizes
the excluded-volume effect.
Estimating α for the Im3m structure involves non-
trivial geometry and knowing the exact lattice parameter,
a, pertaining to our experiments. The value of a used in
Fig. 3 is for fully-hydrated MO cubic phase equilibrated
at 25◦C [10]. These conditions almost certainly do not
apply (after mixing at 25◦C we immediately removed ex-
cess solution and observed at 18◦C). Nevertheless, using
a = 12.5 nm [10] as an estimate, we can approximate
the accessible volume in each water ‘cell’ as a regular
square bipyramid of side 8.8 nm, Fig. 3(b). The centres
of lysozyme molecules can explore a smaller bipyramid of
side 8.8 − σ = 5.4 nm, giving αIm3m ≈ (8.8/5.4)
3 = 4.3
[16]. Literature data for MO under different conditions
without [17] and with lysozyme [10] suggest that we can
expect variations of up to ∼ ±30% in the lattice param-
eter, so that α ∼ 3− 11.
In our simulations, we used small spheres to model
lysozyme, while 125 larger spheres fixed on a primitive
cubic lattice modelled the geometric confinement effect of
the MO cubic phase. Such a model has been used before
to study fluids in porous media [18]. The small sphere
diameter and large-sphere simple cubic lattice constant
were taken to be 3.4 nm and 12.5 nm respectively, to
agree with the known lysozyme molecular volume and
the cubic phase with lysozyme lattice constant at 25◦C
[10]. We simulated a model with a particular α by using
a value for the large sphere diameter such that the small-
sphere centers can access α−1 of the total space between
large spheres. Periodic boundary conditions apply.
The small spheres (diameter σ) interact via a hard core
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FIG. 3: (a) A 2-d projection of the Im3m cubic phase, with
‘necks’ (a-d) connecting water ‘cells’. Annular regions are
lipid bilayers (with lipids shown schematically). Shaded cir-
cles are cross sections of ‘necks’ in and out of the plane of the
paper. Hatched particles are (arbitrarily-placed) lysozymes
with diameter σ = 3.4 nm. The lattice parameter is 12.5 nm.
The larger square (broken line) is the base of a regular square
bipyramid used to model a water ‘cell’. The smaller square is
the base of the (smaller) bipyramid accessible to the centres
of lysozyme molecules. (b) A bipyramid ‘cell’ with lysozyme
molecules.
and a square-well attraction:
u(r) =


+∞, r < σ
−ǫ σ ≤ r < (1 + λ)σ
0 r ≥ (1 + λ)σ
, (1)
where λ and ǫ are the range and depth of the square well
in units of σ and kBT respectively. We took λ = 0.08 [19].
Increasing the salt concentration experimentally corre-
sponds to increasing ǫ; in our range of salinity, we expect
0 < ǫ < 3 [19]. The small spheres behave as hard spheres
to the fixed large spheres.
We investigated the coexistence of a fluid of such at-
tractive small hard spheres confined by a fixed array of
large hard spheres with an unconfined crystal of the at-
tractive hard spheres. This is the thermodynamic situ-
ation of crystals nucleating in mesoscopic defects filled
with concentrated protein solution ‘fed’ from the cubic
phase. Rather than simulating the free energies, we
used an approximation to calculate coexistence by simply
equating chemical potentials and neglecting the equal-
pressure condition (see [20] for a careful justification).
First, in the spirit of the cell model [21] we can approx-
imate the volume accessible to the centre of a particle in
the crystal to be πλ3σ3/6, so that the chemical potential
of the crystal can be written as,
µs = µ0 − ns
( ǫ
2
)
− 3kBT lnλ, (2)
where ns is the number of particles whose centers lie
in the region σ ≤ r < (1 + λ)σ from a given parti-
cle. Here, µ0 = kBT ln(6Λ
3/πσ3) where Λ is the de
Broglie (thermal) wavelength. Note that with this choice
of µ0, the ideal-solution chemical potential is given by
µi = µ0 + kBT lnφ.
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FIG. 4: The excess chemical potential for a fluid with λ = 0.08
at ǫ = 1.5: α = 1 (unconfined, ), 2 (△), 4 (◦), 6 (▽), and 8
(⋄) from simulation. The lines are guides to the eye.
Next, consider the fluid of confined small spheres. The
leading order correction to the ideal limit is
µf = kBT ln(ρaΛ
3) = µi + kBT lnα , (3)
where ρa is the number density of small spheres in the vol-
ume accessible to them, and α−1 is the ratio of this acces-
sible volume to the total volume between large spheres.
In our simulations, α = 2.0, 4.0, 6.0 or 8.0. We used the
‘Widom insertion method’ [22] to obtain ∆µ = µf − µi
at different values of ǫ with and without confinement,
Fig. 4. Note that the confined results indeed go to
∆µ/kBT = lnα in all cases when φ→ 0.
Now we calculate fluid-crystal coexistence at each
value of ǫ by equating the crystal chemical potential,
Equation 2 with ns = 12, to the simulated fluid chem-
ical potential [20]. The low-density branches with and
without confinement are shown in Fig. 5. Increasingly
pronounced confinement indeed systematically decreases
the solubility in a way very reminiscent of the data shown
in Fig. 2.
Quantitatively, we show in the inset that multiplying
the volume fraction φ by α leads to overlap of the phase
boundaries for αφ . 0.2. Note that the same result is
obtained (data not shown) if we map ǫ to the salt con-
centration via measured second virial coefficients [19, 23].
This result suggests that we should attempt the same
procedure on the experimental data. This is problem-
atic. The solubility boundary in cubo cannot be mea-
sured: Fig. 2 shows a nucleation boundary. If we nev-
ertheless proceed, we find that multiplying the lysozyme
concentration by a factor of 4 shifts the confined nucle-
ation boundary to the bulk solubility boundary (inset,
Fig. 2). The in cubo solubility boundary will undoubt-
edly occur at lower concentrations than the nucleation
boundary. We therefore expect that a ‘shift factor’ of
> 4 will be needed to translate the (unavailable) in cubo
solubility boundary to overlap with the bulk solubility
boundary [24]. Given that we expect α ∼ 3 − 11 in our
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FIG. 5: The simulated equilibrium crystallization boundary
with α = 1 (unconfined, ), 2 (△), 4 (◦), 6 (▽), and 8 (⋄).
The lines are guides to the eye. In the inset, the volume
fraction of each system is multiplied by α. This superimposes
all five boundaries at αφ . 0.2.
cubic phase, this expectation is not inconsistent with our
simulation results.
In reporting our experimental findings, we have so far
not mentioned any time-dependent features. Two aspects
are worthy of note. First, we often observed amorphous
precipitates before the appearance of crystals. Unlike
crystals, these precipitates would occur rather uniformly
throughout a sample, and often appeared as ‘stars’ in
the microscope. Sometimes, growing crystals would ‘con-
sume’ surrounding amorphous precipitates. The origin
and nature of these precipitates are unclear. Secondly,
although it is difficult to be quantitative, it is our im-
pression that the in cubo growth of crystals is a slower
process compared to that in bulk solution. This may, of
course, be a reflection of the fact that ‘feeding’ lysozyme
into the growth medium residing in defects is a slow pro-
cess.
To conclude, we have studied the phase behavior of
lysozyme/salt in MO cubic phase. The latter lowers the
solubility of the protein. This is predominantly a confine-
ment effect: experiments and simulations suggest that a
single ‘excluded volume scaling factor’ can shift the solu-
bility boundary back to its bulk position. The altered ki-
netics of crystallization in cubo, relying as we suggest on
defects and other properties of the cubic phase, may of-
fer a new means of controlling protein crystal nucleation
and growth. The generic, entropic, nature of our pro-
posed explanation suggests that lipid cubic phases may
be useful for manipulating a range of nanoparticles, and
for studying the basic statistical physics of confinement.
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